论文信息 - A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco‐Tronic system

A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco‐Tronic system

. Plasma was subjected to methylene blue (MB) photochemical virus inactivation using the Maco Pharma Maco‐Tronic system which allows three units to be illuminated together, thus reducing processing time. The plasma bag system used incorporates an integral membrane plasma filter and a dry MB pill which dissolves in the plasma to give a 1‐µm concentration. There is computer‐controlled processing and datalogging.

[1] C. Prowse,et al. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus‐inactivated plasma , 2000, British journal of haematology.

[2] A. Simonsen,et al. Clinical Tolerance of Methylene Blue Virus–Inactivated Plasma , 1999, Vox Sanguinis.

[3] E. Nicastri,et al. Photodynamic Treatment of Fresh Frozen Plasma by Methylene Blue: Effect on HIV, HCV and Parvovirus B19 , 1999, Transfusion Medicine and Hemotherapy.

[4] C. Prowse,et al. Application of a Time‐Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components , 1999, Vox sanguinis.

[5] H. Mohr. VIRUS INACTIVATION OF PLASMA BY METHYLENE BLUE/LIGHT EXPOSURE , 1999, Pediatric Research.

[6] D. Pamphilon,et al. Leucocytes Can Be Eliminated from Plasma by Filtration Prior to Viral Inactivation with Methylene Blue , 1998, Vox sanguinis.

[7] B. Lambrecht,et al. Photoinactivation of Viruses in Human Fresh Plasma by Phenothiazine Dyes in Combination with Visible Light , 1991, Vox sanguinis.

[8] G. Savidge,et al. Phast assessment of vWf:Ag multimeric distribution. , 1990, Thrombosis research.

[9] C. Prowse,et al. Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis , 1987, Thrombosis and Haemostasis.